Correlation Between Eisai and Takeda Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both Eisai and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eisai and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eisai Co and Takeda Pharmaceutical, you can compare the effects of market volatilities on Eisai and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eisai with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eisai and Takeda Pharmaceutical.

Diversification Opportunities for Eisai and Takeda Pharmaceutical

0.61

Correlation Coefficient

Eisai  Takeda Pharmaceutical

Poor diversification

The 3 months correlation between Eisai and Takeda is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Eisai Co and Takeda Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Eisai is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eisai Co are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Eisai i.e., Eisai and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between Eisai and Takeda Pharmaceutical

Assuming the 90 days horizon Eisai Co is expected to under-perform the Takeda Pharmaceutical. In addition to that, Eisai is 2.47 times more volatile than Takeda Pharmaceutical. It trades about -0.1 of its total potential returns per unit of risk. Takeda Pharmaceutical is currently generating about -0.01 per unit of volatility. If you would invest  2,512  in Takeda Pharmaceutical on September 22, 2024 and sell it today you would lose (11.00) from holding Takeda Pharmaceutical or give up 0.44% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Eisai Co  vs.  Takeda Pharmaceutical

Eisai

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eisai Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Takeda Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Eisai and Takeda Pharmaceutical

The main advantage of trading using opposite Eisai and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eisai position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.

The idea behind Eisai Co and Takeda Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.